Rigetti Computing: Quantum Milestone Meets Market Doubts as Dilution Concerns Grow

Rigetti Computing shares fall to €13.50 as investors weigh CDAC deal against thin revenue, $216M losses, and dilution from ATM program.

Rigetti Computing’s recent contract to supply a 108-qubit quantum computer to India’s CDAC research centre represents a tangible technical achievement, yet it has done little to arrest a sharp sell-off in the stock. The shares slid to €13.50 on Wednesday, cutting 4.4% from Tuesday’s close of €14.12, as investors weighed a promising order pipeline against an increasingly crowded share register and a revenue base that remains wafer-thin.

A Market Split Between Validation and Valuation

The CDAC deal is widely seen as proof that Rigetti’s modular chip design has reached commercial maturity. But the company’s fundamental numbers tell a different story: net losses for 2025 reached $216.2 million on revenue of just $7.09 million — a 34% drop from the prior year. Against that backdrop, the market capitalisation of roughly €4.8 billion yields a triple-digit price-to-sales ratio that even bullishly inclined analysts struggle to justify. Simply Wall St pegs the stock’s fair value at $16, only fractionally above last week’s close of $16.11, while a separate long-term assessment from the same house flags the equity as roughly 70% overvalued. By contrast, a consensus compiled by Pluang shows 85.7% of surveyed analysts with a buy rating and an average price target of $32.67 — implying upside of about 112% from current levels.

ATM Programme Adds to Share-Count Headaches

The widening gap between bulls and bears centres on Rigetti’s heavy reliance on equity-linked financing. Through its “at-the-market” (ATM) programme, the company has raised roughly $100 million by selling new shares directly into the market whenever the stock price ticks up. A further $100 million came in 2026 via a government quantum-funding grant that granted Washington an equity stake. Both moves have strengthened the balance sheet — cash and liquid securities stood at $569 million at the last quarter-end — but they also push up the share count, diluting existing holders. With revenue shrinking, the combination of a stretched valuation, falling top-line and steady dilution worries many market participants.

Technicals Flash Caution Despite Short-Term Bounce

Price action over the past week underscores the stock’s fragility. After a five-day losing streak that erased roughly 12% of value, Rigetti managed a 4.9% rebound on 14 July, when a softer-than-expected US CPI print for June — monthly -0.4% and annual 3.5% — triggered a sector-wide relief rally that also lifted IonQ, D-Wave Quantum and Quantum Computing. That bounce proved short-lived. By Wednesday, the shares had given back those gains and were trading 23.3% below their 50-day moving average of €17.60 and 32.9% below the 200-day average of €20.13. The 14-day relative strength index of 35.4 signals that the stock is approaching oversold territory, yet the annualised 30-day volatility remains elevated at 84.2%.

Broader Macro and Sector Tailwinds Fail to Stick

The broader technology sector enjoyed a more constructive session on 15 July, lifted by strong earnings and an upgraded outlook from chip-equipment maker ASML, but Rigetti failed to join the advance. Analysts point to a confluence of macro headwinds — rising Middle East tensions, climbing oil prices and lingering questions about the commercialisation timeline for quantum computing — that have made investors increasingly selective. At a 72% discount to its 52-week high of €50.30 from October 2025, and having bounced just 22.8% off the March 2026 trough of €11.00, the stock remains caught between bargain hunters betting on a technical recovery and those waiting for hard evidence that the order pipeline can catch up with a stock price that has already priced in considerable success.